Roches NVIDIA AI Factory: 3,500 GPUs, Digital Twins & Omniverse for GLP-1 Manufacturing Executive Summary: Roche the global biotech and diagnostics leader has dramatically scaled its AI and computing infrastructure through a new partnership with NVIDIA
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
Because of this, a B12 deficiency can interrupt the intricate processes involved in immunity, weakening your bodys defense system against disease
this is being followed by the anticipated Q2 2026 approval of Eli Lilly's orforglipron, the first non-peptide small-molecule pill in this class
Obesity not only increases the risk of developing type 2 diabetes but also exacerbates complications and related comorbidities, such as cardiovascular disease, cancer, and osteoarthritis, while decreasing life expectancy and increasing health care costs
Research Use Only This product is intended for laboratory research purposes only and is not for human or animal consumption